Sullivan Christopher Ryan
CIK 1810417
Transactions on file
21
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | 2026-08-18 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 31,031 | $622.3K | -4.1% | open → |
| 2026-08-19 | 2026-08-18 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 31,031 | $306.6K | +94.6% | open → |
| 2026-08-19 | 2026-08-17 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 3,749 | $74.8K | -3.6% | open → |
| 2026-08-19 | 2026-08-17 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 37,945 | $753.3K | -3.1% | open → |
| 2026-08-19 | 2026-08-17 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 2,876 | $28.4K | +94.6% | open → |
| 2026-08-19 | 2026-08-17 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 37,945 | $374.9K | +94.6% | open → |
| 2026-06-12 | 2026-06-10 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Tax | 138 | $1.8K | +46.8% | open → |
| 2026-05-26 | 2026-05-21 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Grant | 39,900 | $0.00 | — | open → |
| 2026-05-11 | 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 18,606 | $448.8K | -20.3% | open → |
| 2026-05-11 | 2026-05-07 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 18,606 | $183.8K | +94.6% | open → |
| 2025-04-01 | 2025-03-28 | AVTX Avalo Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 24,200 | — | — | open → |
| 2025-04-01 | 2025-03-28 | AVTX Avalo Therapeutics, Inc. | Officer Chief Financial Officer | Tax | 7,285 | $61.6K | +127.3% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 8,900 | $200.9K | -14.8% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 9,219 | $197.0K | -10.0% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 2,700 | $56.1K | -7.4% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 12,347 | $238.1K | -0.3% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 13,834 | $256.7K | +3.7% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Exer. | 47,000 | $377.9K | +139.2% | open → |
| 2026-05-01 | 2026-04-30 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 8,457 | $111.9K | +45.4% | open → |
| 2026-05-01 | 2026-04-29 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Sale | 8,458 | $110.7K | +46.9% | open → |
| 2025-12-12 | 2025-12-10 | AVTX Avalo Therapeutics, Inc. | Officer Chief Financial Officer | Tax | 155 | $635.50 | +369.0% | open → |
